These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 31151999)
1. Gamma-Glutamyltransferase 1 Promotes Clear Cell Renal Cell Carcinoma Initiation and Progression. Bansal A; Sanchez DJ; Nimgaonkar V; Sanchez D; Riscal R; Skuli N; Simon MC Mol Cancer Res; 2019 Sep; 17(9):1881-1892. PubMed ID: 31151999 [TBL] [Abstract][Full Text] [Related]
2. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
3. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma. Priolo C; Khabibullin D; Reznik E; Filippakis H; Ogórek B; Kavanagh TR; Nijmeh J; Herbert ZT; Asara JM; Kwiatkowski DJ; Wu CL; Henske EP Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6274-E6282. PubMed ID: 29891694 [TBL] [Abstract][Full Text] [Related]
4. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation. Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma. Chan Y; Yu Y; Wang G; Wang C; Zhang D; Wang X; Wang Z; Jian W; Zhang C Med Sci Monit; 2019 Jul; 25():5181-5190. PubMed ID: 31299041 [TBL] [Abstract][Full Text] [Related]
6. RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma. Liu Y; Cheng G; Song Z; Xu T; Ruan H; Cao Q; Wang K; Bao L; Liu J; Zhou L; Liu D; Yang H; Chen K; Zhang X Int J Oncol; 2019 Sep; 55(3):645-656. PubMed ID: 31364727 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma. Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway. Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913 [TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma. Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778 [TBL] [Abstract][Full Text] [Related]
10. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma. Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533 [TBL] [Abstract][Full Text] [Related]
11. TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma. Jiang B; Chen W; Qin H; Diao W; Li B; Cao W; Zhang Z; Qi W; Gao J; Chen M; Zhao X; Guo H Cancer Lett; 2019 May; 449():76-86. PubMed ID: 30772441 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma. Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834 [TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway. Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137 [TBL] [Abstract][Full Text] [Related]
14. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway. Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860 [TBL] [Abstract][Full Text] [Related]
15. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma. Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827 [TBL] [Abstract][Full Text] [Related]
16. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling. He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912 [TBL] [Abstract][Full Text] [Related]
17. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance. Ho PY; Chueh SC; Chiou SH; Wang SM; Lin WC; Lee IL; Yang HY; Peng HC; Lai MK Urol Oncol; 2013 Oct; 31(7):1367-77. PubMed ID: 22417627 [TBL] [Abstract][Full Text] [Related]
18. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173 [TBL] [Abstract][Full Text] [Related]
20. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]